1542 / 1851
Risk group
Histology
Adjuvant treatment
Low
Ia, G1-2, LVSI -ve None
Intermediate Ib, G1-2, LVSI -ve BT or none if <60
With LND
No LND
High-
intermediate
Ib, G1-2, LVSI +ve
Ia, G3
BT or none BT if G3 and LVSI -
EBRT if LVSI+
Colombo N. Radiother Oncol. 2015;117(3):559-81
ESMO-ESGO-ESTRO recommendations 2015
4 risk groups
LVSI must be unequivocally positive (not focal)